Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 161628, 16 pages
http://dx.doi.org/10.1155/2013/161628
Research Article

Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma

1Graduate Institute of Life Sciences, National Defense Medical Center, No. 161, Sec. 6, Minquan E. Road, Neihu District, Taipei 114, Taiwan
2Department of Pathology and Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, No. 161, Sec. 6, Minquan E. Road, Neihu District, Taipei 114, Taiwan
3Biobank Management Center of Tri-Service General Hospital, National Defense Medical Center, No. 161, Sec. 6, Minquan E. Road, Neihu District, Taipei 114, Taiwan
4School of Pharmacy, National Defense Medical Center, No. 161, Sec. 6, Minquan E. Road, Neihu District, Taipei 114, Taiwan
5Division of Urology, Tri-Service General Hospital, National Defense Medical Center, No. 161, Sec. 6, Minquan E. Road, Neihu District, Taipei 114, Taiwan

Received 18 February 2013; Accepted 17 April 2013

Academic Editor: Shuang-En Chuang

Copyright © 2013 Jar-Yi Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jar-Yi Ho, Ren-Jun Hsu, Chieh-Lin Wu, et al., “Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 161628, 16 pages, 2013. https://doi.org/10.1155/2013/161628.